Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Steady Operations NPK Q3 2023 Earnings Modest Profit Amid Quiet Quarter BLNK Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline VVOS Q4 2025 Earnings EPS Misses Estimates as Loss Widens Stock Gains 431 AWK Q1 2026 Earnings EPS Misses Estimates as Shares Edge Higher GBX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Despite Stock Gain RBLX Q1 2026 Earnings EPS Beat Drives Positive Market Reaction HSIC Q1 2026 Earnings Strong EPS Beat Amid Solid Operational Performance CREX Q1 2026 Earnings EPS Falls Sharply Below Estimates Despite Positive Stock Reaction Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline TEM Q1 2026 Earnings Narrower Loss Surprises Analysts but Stock Slides EQBK Q1 2026 Earnings EPS Misses Estimates Yet Stock Shows Resilience